Monoclonal antibody-conjugated immunotherapy of cancer

International Reviews of Immunology

Volumn 14, Issue 2-3, 1997, Pages 213-227

  Imai, Kohzoh ^a   Hareyama, Masato ^a   Makiguchi, Yusuke ^a   Matsumoto, Hiroyuki ^a   Hinoda, Yuji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030934323     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189709116853     Document Type: Review

References (31)

1. Lloyd, K.O., and Old, L.J. Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients. Cancer Res. 49, 3445-3451, 1989.
2. Imai, K., Moriya, Y., Fujita, H., Tsujisaki, M., Kawaharada, M., and Yachi, A. Immunologic characterization and molecular profile of carcinoembryonic antigen detected by monoclonal antibodies. J. Immunol. 132, 2992-2997, 1984.
3. Uyama, I., Kumai, K., Yasuda, T., Tagawa, T , Ishibiki, K., Kitajima, M., and Tadakuma, T. Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. Jpn. J. Cancer Res. 85, 434-440, 1994.
4. Nassander, U.K., Steerenberg, P.A., Poppe, H., Storm, G., Poels, L.G., De-Jong, W.H., and Crommelin, D.J. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. Cancer Res. 52, 646-653, 1992.
5. Colcher, D., Milenic, D.E., and Ferroni, P. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer. J. Nucl. Med. 37, 1133-1142, 1990.
6. Otsuji, E., Yamaguchi, T., Yamaoka, N., Taniguchi, K., Kato, M., Kotani, T., Kitamura, K., and Takahashi, T. Biodistribution of neocarzinostatin conjugated to chimeric Fab fragments of the monoclonal antibody A7 in nude mice bearing human pancreatic cancer xenografts. Jpn. J. Cancer Res. 85, 530-535, 1994.
7. LoBuglio, A.F., Saleh, M.N., Lee, J., Khazaeli, M.B., Carrano, R., Holden, H., and Wheeler, R.H. Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspects. J. Natl. Cancer Inst. 80, 932-936, 1988.
8. Khazaeli, M.B., Saleh, M.N., Wheeler, R.H., Huster, W.J., Holden, H., Carrano, R., and LoBuglio, A.F. Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A II. Pharmacokinetics and immune response. J. Natl. Cancer Inst. 80, 937-942, 1988.
9. Courtenay-Luck, N.S., Epenetos, A.A., Moore, R., Larche, M., Pectasides, D., Dhokia, B., and Ritter, M.A. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res. 46, 6489-6493, 1986.
10. Boulianne, G.L., Hozumi, N., and Shulman, M.J. Production of functional chimeric mouse/human antibody. Nature 312, 643-646, 1984.
11. Morrison, S.L., Johnson, M.J., Herzenberg, L., and Oi, V.T. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. USA 81, 6851-6855, 1984.
12. Riechmann, L., Clark, M., Waldmann, H., and Winter, G. Reshaping human antibodies for therapy. Nature 332, 323-327, 1988.
13. Sahagan, B.G., Dorai, H., Saltzgaber-Muller, J., Toneguzzo, F., Guindon, C.A., Lilly, S.P., McDonald, K.W., Morrissey, D.V., Stone, B.A., Davis, G.L., McIntosh, P.K., and Moore, G.P. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen. J. Immunol. 137, 1066-1074, 1986.
14. 97-specific Fab fragments in human melanoma as a basis for radiotherapy. J. Clin. Invest. 72, 2101-2114, 1983.
15. LoBuglio, A.F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Hervey, E.B., Sun, L., Ghrayeb, J., and Khazaeli, M.B. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc. Natl. Acad. Sci. USA 86, 4220-4224, 1989.
16. 131I-chimeric mouse/human B72.3 (human 4) monoclonal antibody in humans. Cancer Res. 51, 5461-5466, 1991.
17. Liu, A.Y., Robinson, R.R., Hellstrom, K.E., Murray, E.D , Chang, C.P., and Hellstrom, I. Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells Proc. Natl Acad. Sci. USA 84, 3439-3443, 1987.
18. Nishimura, Y., Yokota, M., Akira, K., Ueda, R., Kudo, A., and Watanabe, T. Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen. Cancer Res. 47, 999-1005, 1987.
19. Ishida, T., Tsujisaki, M., Hinoda, Y., Imai, K., and Yachi, A. Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product. Jpn. J. Cancer Res. 85, 172-178, 1994.
20. 111indium labeled anticarcinoembryonic antigen monoclonal antibody. Cancer Res 46, 6494-6502, 1986.
21. Beatty, J.D., Williams, L E., Yamauchi, D., Morton, B A., Hill, L.R., Beatty, B.G., Paxton, R.J., Merchant, B., and Shively, J.E. Presurgical imaging with indium labeled anti-carcinoembryonic antigen for colon cancer staging. Cancer Res. 50 (Suppl.), 922-926, 1990.
22. Sardi, A , Agnone, C.M., Nieroda, C.A., Mojzisik, C., Hinkle, G., Ferrara, P., Farrar, W.B., Bolton, J., Thurston, M.O., and Martin, E.W. Radioimmunoguided surgery in recurrent colorectal cancer: The role of carcinoembryonic antigen, computerized tomography, and physical examination. Southern Med. J. 82, 1235-1244, 1989.
23. Dykes, P.W., Bradwell, A.R., Chapman, C.E., and Vaugh, A.T.M. Radioimmunotherapy of cancer: clinical studies and limiting factors. Cancer Treat. Rev. 14, 87-106, 1987.
24. Neumaier, M., Shively, L., Chen, F.S., Gaida, F.-J., Ilgen, C., Paxton, R.J., Shively, J.E., and Riggs, A.D. Cloning of the genes for T84.66, an antibody that has a high-specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. Cancer Res. 50, 2128-2134, 1990.
25. Hutzell, P., Kashmiri, S., Colcher, D., Primus, F.J., Hand, P.H., Roselli, M., Finch, M., Yarranton, G., Bodmer, M., Whittle, N., King, D., Loullis, C.C., McCoy, D.W., Callahan, R., and Schlom, J. Generation and characterization of a recombinant/chimeric B72.3 (human 1). Cancer Res. 51, 181-189, 1991.
26. Santos, O., Pant, K.D., Blank, E.W., and Ceriani, R.L. 5-iododeoxyuridine increases the efficacy of the radio-immunotherapy of human tumors growing in nude mice. J. Nucl. Med. 33, 1530-1534, 1992.
27. 212Bi-anti-Tac. Cancer Res. 54, 4362-370, 1994.
28. Calvete, J.A., Newell, D.R., Wright, A.F., and Rose, M.S. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer. Cancer Res. 54, 4684-4690, 1994.
29. Zangemeister-Wittke, U., Collinson, A.R , Frösch, B., Waibel, R., Schenker, T., and Stahel, R.A. Immunotoxins recognizing a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer. Br. J. Cancer 69, 32-39, 1994.
30. Zalcberg, J.R., Pietersz, G., Toohey, B., Laird, J., Huggins, R., Zimet, A.S., Hennessy, O , McKenzie, A., and McKenzie, I.F.C. A phase I/II study of the intralesional injection of ricin-monoclonal antibody conjugates in patients with hepatic metastases. Eur. J. Cancer 30A, 1227-1231, 1994.
31. HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. USA 92, 1327-1331, 1995.